Leslie J Williams

Leslie J Williams is a distinguished leader in the biotechnology and life sciences sectors, serving as Co-Founder, President, and CEO of hC Bioscience, Inc. since February 2021, where innovative protein editing using engineered tRNA is pursued. Additional roles include Board Member at the Biotechnology Innovation Organization and Ocular Therapeutix, Inc., Operating Partner at Accelerator Life Science Partners, and Executive in Residence at both the University of Virginia and University of Iowa. Leslie J Williams previously held a similar title at ImmusanT, Inc., focusing on therapeutic vaccines for autoimmune diseases. An educational background includes an MBA from Washington University in St. Louis and a certificate in Immunology from Harvard Medical School.